JAYSON SMITH: Open Payments
NPI 1982202743 · BOISE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 13 payments from 10 companies in 2025. Trend: 2023 $54 · 2024 $42 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| Kite Pharma, Inc. | 1 | $104 |
| ABBVIE INC. | 4 | $94 |
| Medtronic, Inc. | 1 | $26 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $22 |
| Viatris Specialty LLC | 1 | $18 |
| Boston Scientific Corporation | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: Yescarta, UBRELVY, INCEPTIV, JARDIANCE, TRELEGY ELLIPTA, YUPELRI, General - Pain Management, MOUNJARO.
Industry payments across ID — which companies pay providers there.
